Acute Myeloid Leukemia Minimal Residual Disease Detection: The Difference from Normal Approach
{{output}}
The identification of residual leukemia following therapy, termed minimal or measurable residual disease (MRD), has emerged as one of the most important prognostic factors for patients with acute leukemia, including acute myeloid leukemia (AML). Flow cytometry... ...
